WallStreetZenWallStreetZen

NASDAQ: TERN
Terns Pharmaceuticals Inc Stock

Open Broker Account
$5.16+0.27 (+5.52%)
Updated Sep 23, 2022
TERN Price
$5.16
Fair Value Price
$5.82
Market Cap
$130.88M
52 Week Low
$1.45
52 Week High
$11.30
P/E
-2.41x
P/B
0.95x
P/S
62.76x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.00M
Earnings
-$53.79M
Gross Margin
100%
Operating Margin
-5,330.4%
Profit Margin
-5,378.6%
Debt to Equity
0.06
Operating Cash Flow
-$43M
Beta
0.85
Next Earnings
Nov 14, 2022
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TERN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TERN ($5.16) is undervalued by 11.4% relative to our estimate of its Fair Value price of $5.82 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
TERN ($5.16) is not significantly undervalued (11.4%) relative to our estimate of its Fair Value price of $5.82 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
TERN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more TERN due diligence checks available for Premium users.

Be the first to know about important TERN news, forecast changes, insider trades & much more!

TERN News

Valuation

TERN fair value

Fair Value of TERN stock based on Discounted Cash Flow (DCF)
Price
$5.16
Fair Value
$5.82
Undervalued by
11.40%
TERN ($5.16) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
TERN ($5.16) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
TERN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

TERN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.41x
Industry
15.88x
Market
27.65x

TERN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.95x
Industry
4.31x
TERN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

TERN's financial health

Profit margin

Revenue
$0.0
Net Income
-$13.9M
Profit Margin
0%
TERN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
TERN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$144.9M
Liabilities
$7.6M
Debt to equity
0.06
TERN's short-term assets ($142.60M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TERN's short-term assets ($142.60M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TERN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$11.2M
Investing
-$16.0M
Financing
$124.0k
TERN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

TERN vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
TERN$130.88M+5.52%-2.41x0.95x
OVID$130.28M-3.65%-1.89x0.86x
TNYA$131.54M-2.15%-2.16x0.59x
FUSN$131.91M+2.01%-1.74x0.66x
IKNA$128.71M+2.60%-2.96x0.74x

Terns Pharmaceuticals Stock FAQ

What is Terns Pharmaceuticals's quote symbol?

NASDAQ: TERN) Terns Pharmaceuticals trades on the NASDAQ under the ticker symbol TERN. Terns Pharmaceuticals stock quotes can also be displayed as NASDAQ: TERN.

If you're new to stock investing, here's how to buy Terns Pharmaceuticals stock.

What is the 52 week high and low for Terns Pharmaceuticals (NASDAQ: TERN)?

(NASDAQ: TERN) Terns Pharmaceuticals's 52-week high was $11.30, and its 52-week low was $1.45. It is currently -54.34% from its 52-week high and 255.86% from its 52-week low.

How much is Terns Pharmaceuticals stock worth today?

(NASDAQ: TERN) Terns Pharmaceuticals currently has 25,363,829 outstanding shares. With Terns Pharmaceuticals stock trading at $5.16 per share, the total value of Terns Pharmaceuticals stock (market capitalization) is $130.88M.

Terns Pharmaceuticals stock was originally listed at a price of $19.79 in Feb 8, 2021. If you had invested in Terns Pharmaceuticals stock at $19.79, your return over the last 1 years would have been -73.93%, for an annualized return of -73.93% (not including any dividends or dividend reinvestments).

How much is Terns Pharmaceuticals's stock price per share?

(NASDAQ: TERN) Terns Pharmaceuticals stock price per share is $5.16 today (as of Sep 23, 2022).

What is Terns Pharmaceuticals's Market Cap?

(NASDAQ: TERN) Terns Pharmaceuticals's market cap is $130.88M, as of Sep 27, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Terns Pharmaceuticals's market cap is calculated by multiplying TERN's current stock price of $5.16 by TERN's total outstanding shares of 25,363,829.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.